Specialties: CANNABIS INVESTMENTS
Danny Brody is the director of investor relations at Emblem Corp. (TSX-V:EMC), the parent company of Emblem Cannabis. Coming from the capital markets team that helped Emblem go public, Mr. Brody has an in-depth understanding of all aspects of the company’s corporate structure, qualifying transactions, and is now an expert in the cannabis space. He, along with the capital advisory team behind Emblem’s fundraising, have collectively raised $31.7 million for Emblem. Emblem Corp. is a fully integrated licensed producer of medical marijuana in Canada, led by a team of former healthcare and pharmaceutical executives who have built and run multi-billion-dollar companies.